Abstract
To determine effective and efficient monitoring criteria for ocular hypertension [raised intraocular pressure (IOP)] through (i) identification and validation of glaucoma risk prediction models; and (ii) development of models to determine optimal surveillance pathways.
| Original language | English |
|---|---|
| Pages (from-to) | 1-271, iii-iv |
| Journal | Health Technology Assessment |
| Volume | 16 |
| Issue number | 29 |
| DOIs | |
| Publication status | Published - 2012 |